Studies (up to 31 October 2019)

The total number of studies listed on this site is 3145.

Research Proposals requesting access to patient level data (up to 30 September 2019)

A summary of the number of Research Proposals received via this site since May 2013 is provided here and is updated monthly.

The table below provides metrics for different parts of the process following submission of a Research Proposal (Requirements check, Independent Review Panel (IRP) review, Data Sharing Agreement, Data preparation, Data Access and Publication). The "In process" rows provide the number of Research Proposals in this part of the process. The other rows for each part of the process provide the total number of Research Proposals that have achieved that outcome.

Number of Research Proposals submitted up to 30 September 2019 543
Requirements check In process 32
Withdrawn by the requestor 49
No response received 24
Did not meet requirements (further details) 23
Potential conflict of interest or an actual or potential competitive risk 0
Met requirements 415
IRP review In process 6
Withdrawn by the requestor 4
No response received 2
Rejected or advised to re-submit 60
Approved or approved with conditions 343
Data Sharing Agreement In process 36
Withdrawn by the requestor 18
No response received 10
Not agreed by requestor 1
Agreed (signed) View details of these Research Proposals 277
Data preparation In process 8
Withdrawn by the requestor 1
No response received 2
Complete (data available) 266
Data Access Access provided 142
Withdrawn by the requestor 2
Access closed 122
Publication anticipated 35
View details of these Research Proposals
Withdrawn by requestor 13
No response received 20
Publication not received after 18 months of Access Closed 9

Multi-Sponsor Research Proposals were possible starting 1 January 2014. Out of 521 proposals submitted since 1 January 2014, 87 were multi-Sponsor proposals.

Enquiries related to non-listed studies (up to 30 September 2019)

A summary of the number of Enquiries received via this site since May 2013 is provided here and is updated every 3 months.

The table below provides information on the number of non-listed studies for which Enquiries were received via Enquiries received outside the system, general Enquiries not related to accessing patient level data, Enquiries requesting access to documents only and Enquiries for specific data points are not included in these metrics.

Study Sponsor/Funder Number of non-listed studies requested Number of studies undergoing feasibility assessments Number of studies with a positive response1 Number of studies with a negative response2
Astellas 62 5 9 48 (further details)
Boehringer Ingelheim 74 0 43 31 (further details)
Daiichi Sankyo 2 1 0 2 (further details)
Eisai 67 0 6 61 (further details)
GSK 280 2 211 67 (further details)
Lilly 205 0 92 113 (further details)
Novartis 253 11 69 173 (further details)
Roche1 239 68 48 123 (further details)
Sanofi 130 19 24 87 (further details)
Takeda 100 0 23 77 (further details)
UCB 41 6 28 31 (further details)
ViiV Healthcare 8 0 8 0

1 Study to be listed on and researcher able to submit a Research Proposal, or access to the requested data is otherwise enabled.

2 Study will not be listed on / access to data cannot be provided.